PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

about

Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT.

P2860

Q35575497-B8A7EBEB-B048-48CE-870D-D8529C501974

P2860

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

Item

http://www.wikidata.org/entity/Q35575502

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

@ast

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

@en

type

Item

label

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

@ast

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

@en

prefLabel

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

@ast

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

@en

P1476

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

@en

P2093

D O Kiesewetter

http://www.w3.org/2001/XMLSchema#string

Karen A Kurdziel

http://www.w3.org/2001/XMLSchema#string

P2860

Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells

Biochemistry of multidrug resistance mediated by the multidrug transporter

Graphical analysis of PET data applied to reversible and irreversible tracers.

Visualization of multidrug resistance in vivo.

Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.

Automated synthesis of 18F analogue of paclitaxel (PAC): [18F]Paclitaxel (FPAC).

Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.

Preclinical pharmacokinetics of paclitaxel and docetaxel.

Imaging multidrug resistance with 4-[18F]fluoropaclitaxel.

Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.

P304

1792-1798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/156802610792928077

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20645913

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

3224980

http://www.w3.org/2001/XMLSchema#string

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

about

P2860

P2860

PET imaging of multidrug resistance in tumors using 18F-fluoropaclitaxel.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932